Skip to main content

Table 2 Proportion influenza and RSV positive by GBD super-region

From: Hospital utilization rates for influenza and RSV: a novel approach and critical assessment

GBD super region Age Influenza positive proportion of ALRI admissions (95% UI) RSV positive proportion of ALRI admissions (95% UI)
Central Europe, Eastern Europe, and Central Asia < 1 year 0.06 (0.01–0.25) 0.39 (0.14–0.72)
Central Europe, Eastern Europe, and Central Asia 1 to 4 0.08 (0.01–0.31) 0.24 (0.07–0.55)
Central Europe, Eastern Europe, and Central Asia 5 to 17 0.22 (0.03–0.63) 0.08 (0.02–0.23)
Central Europe, Eastern Europe, and Central Asia 18 to 49 0.26 (0.04–0.68) 0.03 (0.01–0.1)
Central Europe, Eastern Europe, and Central Asia 50 to 64 0.1 (0.01–0.35) 0.01 (0–0.03)
Central Europe, Eastern Europe, and Central Asia 65 plus 0.02 (0–0.09) 0 (0–0.01)
High-income < 1 year 0.06 (0.01–0.23) 0.36 (0.12–0.68)
High-income 1 to 4 0.08 (0.01–0.29) 0.22 (0.06–0.51)
High-income 5 to 17 0.21 (0.03–0.62) 0.07 (0.02–0.2)
High-income 18 to 49 0.25 (0.04–0.67) 0.03 (0.01–0.08)
High-income 50 to 64 0.09 (0.01–0.34) 0.01 (0–0.03)
High-income 65 plus 0.02 (0–0.08) 0 (0–0.01)
Latin America and Caribbean < 1 year 0.05 (0–0.19) 0.43 (0.16–0.76)
Latin America and Caribbean 1 to 4 0.06 (0.01–0.24) 0.27 (0.08–0.6)
Latin America and Caribbean 5 to 17 0.18 (0.02–0.56) 0.09 (0.02–0.26)
Latin America and Caribbean 18 to 49 0.21 (0.03–0.62) 0.03 (0.01–0.11)
Latin America and Caribbean 50 to 64 0.07 (0.01–0.29) 0.01 (0–0.04)
Latin America and Caribbean 65 plus 0.01 (0–0.07) 0 (0–0.01)
North Africa and Middle East < 1 year 0.05 (0–0.19) 0.32 (0.1–0.66)
North Africa and Middle East 1 to 4 0.06 (0.01–0.25) 0.19 (0.05–0.48)
North Africa and Middle East 5 to 17 0.18 (0.02–0.56) 0.06 (0.01–0.18)
North Africa and Middle East 18 to 49 0.21 (0.03–0.61) 0.02 (0–0.07)
North Africa and Middle East 50 to 64 0.07 (0.01–0.29) 0.01 (0–0.03)
North Africa and Middle East 65 plus 0.02 (0–0.07) 0 (0–0)
South Asia < 1 year 0.04 (0–0.18) 0.33 (0.1–0.67)
South Asia 1 to 4 0.06 (0.01–0.23) 0.19 (0.05–0.49)
South Asia 5 to 17 0.17 (0.02–0.54) 0.06 (0.01–0.18)
South Asia 18 to 49 0.2 (0.03–0.59) 0.02 (0–0.07)
South Asia 50 to 64 0.07 (0.01–0.27) 0.01 (0–0.03)
South Asia 65 plus 0.01 (0–0.06) 0 (0–0)
Southeast Asia, East Asia, and Oceania < 1 year 0.08 (0.01–0.29) 0.31 (0.1–0.64)
Southeast Asia, East Asia, and Oceania 1 to 4 0.1 (0.01–0.36) 0.19 (0.05–0.46)
Southeast Asia, East Asia, and Oceania 5 to 17 0.26 (0.04–0.68) 0.06 (0.01–0.17)
Southeast Asia, East Asia, and Oceania 18 to 49 0.3 (0.05–0.73) 0.02 (0–0.07)
Southeast Asia, East Asia, and Oceania 50 to 64 0.11 (0.01–0.41) 0.01 (0–0.02)
Southeast Asia, East Asia, and Oceania 65 plus 0.03 (0–0.11) 0 (0–0)
Sub-Saharan Africa < 1 year 0.04 (0–0.16) 0.42 (0.15–0.75)
Sub-Saharan Africa 1 to 4 0.05 (0–0.21) 0.27 (0.08–0.59)
Sub-Saharan Africa 5 to 17 0.15 (0.02–0.49) 0.09 (0.02–0.26)
Sub-Saharan Africa 18 to 49 0.18 (0.02–0.55) 0.03 (0.01–0.11)
Sub-Saharan Africa 50 to 64 0.06 (0.01–0.24) 0.01 (0–0.04)
Sub-Saharan Africa 65 plus 0.01 (0–0.06) 0 (0–0.01)
  1. Proportion of ALRI admissions that are influenza and RSV positive for all IHME super-regions stratified by BIRD age group